Please login to the form below
Greater Manchester
This page shows the latest Greater Manchester news and features for those working in and with pharma, biotech and healthcare.
AstraZeneca joins UK pilot evaluating AI-based lung cancer diagnosis system
AstraZeneca (AZ) is partnering with artificial intelligence (AI) tech company Qure.ai and the Greater Manchester Cancer Alliance to evaluate whether an AI system can help radiologists make faster and more ... of these X-rays when it is needed the
Latest news
-
Millions invited to take part in UK’s largest health research programme
Working in collaboration with NHS DigiTrials, the programme will send invites to adults aged 18 years and over to residents of West Yorkshire, West Midlands, Greater Manchester and Greater London.
-
Mistrust of pharma still blocking NHS collaborations
Greater Manchester is leader in breaking down barriers. What’s stopping pharma and the NHS working together more often, and in more parts of the UK? ... Greater Manchester and its devolved and combined health and social care budget is not only at the
-
Greater Manchester backs move to outcome-based payment
Now England’s leading devolved health region, Greater Manchester, has teamed up with charity Cancer Research UK to look at how to adopt the new approach. ... As well many new outcomes-based deals being agreed between the industry and new regional
-
UK’s genomics leadership attracts IQVIA investment, regardless of Brexit
The Northern Prime Site will include NHS research-ready hospitals across the Greater Manchester, Leeds and Sheffield region, and the new site will employ a data-enabled approach to the design
-
UK pharma to work with innovation network on NHS uptake
The arrangement was propelled forward based on similar regional-level agreements. According to the ABPI, related agreements made for specific disease areas have also demonstrated positive results, including the Greater Manchester
More from news
Approximately 3 fully matching, plus 17 partially matching documents found.
Latest Intelligence
-
25 Women Leaders in UK Healthcare (part 2)
18. SARAH PRICE . Population health leader. Greater Manchester is the pioneer that is leading England’s health and social care into the future, away from the old siloed, disjointed services towards ... Another major problem being tackled is
-
Unlocking the potential of science and technology in the UK
Alderley Park also has two venture funds based here, one of which, the £42m Greater Manchester and Cheshire Life Science Fund, has already invested in 25 businesses across pharmaceuticals, biotech, diagnostics, ... That’s not about the old North v
-
NHS regional footprints
In some localities like greater Manchester these CCGs already mirror the STP and they will form the organisations responsible for strategic commissioning, which is concerned with meeting outcomes within a whole ... The regulators said this would provide
-
New models of NHS care – new models of pharma response?
There are now 14 integrated care systems (ICSs) operating in England, as well as more devolved areas such as Greater Manchester and Surrey Heartlands.". ... Greater Manchester leading integration. Greater Manchester is England's most advanced integrated
-
Pharma: in search of the sustainable ‘win win’ with the NHS
Greater Manchester is a trailblazer for integrated care in England. She says Greater Manchester’s Health and Social Care Partnership, which covers 2.8m people in the north west of England,
More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.
Latest from PMHub
-
Spending on anti-depressants soars as the pandemic’s effect on NHS prescribing patterns is revealed
£2, 605), Our Dorset (£2, 610) and Greater Manchester Health &Social Care Partnership (£2, 640), where hospital admissions were comparatively high.
-
Managing local population needs is key for the NHS
health and care systems in Greater Manchester and Surrey Heartlands, as well as the eight shadow accountable care systems. ... efficiencies. Conclusion. STPs and the newly emerging ICS models will be key to driving change within the NHS by allowing it
-
How can pharma engage with the top performing STPs?
care); Greater Manchester (surgery) West, North and East Cumbria (cancer care).
-
HAVAS LYNX MEDICAL
Address:. 52 Princess Street. Manchester. Greater Manchester. M1 6JX. UK.
-
Raw Design Studio
Salford. Greater Manchester. M3 5HW. UK.
More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.
Subscribe to our email news alerts
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Technical Sales Representative
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- LEO Pharma enters clinical trial partnership with ICON
- Results for Astellas’ non-hormonal menopause drug published in The Lancet
- Roche’s Polivy backed by FDA Advisory Committee for lymphoma therapy
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- How to create content for health professionals
- Sanofi to cut US insulin prices by up to 78% in January 2024
- Pfizer and Astellas’ Xtandi shows promise in phase 3 prostate cancer study
- 2023 PM Society Awards – winners announced
- Next congress, please: making the most of virtual pharmaceutical congresses
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- Locus Biosciences announces first patient treated in urinary tract infection trial
- A relentless commitment to neuroscience
- AstraZeneca announces major expansion of Canadian research footprint
- BMS will not launch cancer drug Opdualag in Germany due to pricing pressures
- Neurodiversity and healthcare communications – do we know enough and do we do enough?
PMHub
BOLDSCIENCE
We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...
Latest intelligence
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
- WHY ARE PATIENT SUPPORT PROGRAMMES NOT WORKING?
- By offering patients knowledge, skills and confidence, they empower patients to be more actively involved in their health. Holistic support can help tackle adherence, mental health or anything else patients...
- THE EVOLVING ROLE OF PROCUREMENT?
- Procurement is evolving to reinforce its position as a strategic enabler of company growth. How can agency partners organisations to realise this?...
